A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy
A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy
A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy
Status
Status :
Completed
Type of study
Phase I
Min. Age
-
Max. Age
-
Gender
All
Therapeutic area :
Dermatology
Disease :
Infantile hemangioma
Study medication :
Propranolol (Hemangiol®)
Phase :
Phase I
Start Date :
26 March 2010
End date :
29 May 2012
Study ID :
V00400 SB 102
EudraCT/CTIS number :
2009-018102-22
Send by email